RxDoctor Payments Data

Richard Irvin

Family Medicine · Wheeling, WVNPI 1083603336

Payments from drug & device makers

$318in general payments, 2019–2025

Across 18 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$58
  • Novo Nordisk$39
  • Nevro Corp.$36
  • AbbVie$32
  • E.r. Squibb & Sons, L.L.C.$27
  • AstraZeneca$25
  • plus $102 from 6 others

What the payments were for

  • Food & beverage$318100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$318 in reported general payments places this provider in the 45th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$46,050
Medicare patients
244
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$96,405
EliquisApixaban51$58,230
TrulicityDulaglutide40$44,473
JanuviaSitagliptin Phosphate23$36,760
MounjaroTirzepatide34$34,759
JardianceEmpagliflozin25$33,215
XareltoRivaroxaban14$19,044
Spiriva HandihalerTiotropium Bromide36$17,517
Tresiba Flextouch U-200Insulin Degludec12$15,209
Tresiba Flextouch U-100Insulin Degludec24$12,938
FarxigaDapagliflozin Propanediol13$11,969
MyrbetriqMirabegron16$9,904
Incruse ElliptaUmeclidinium Bromide22$8,307
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$8,222
EntrestoSacubitril/Valsartan12$8,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$39$96,40586 claims
Lilly USA, LLCTrulicity, Mounjaro$20$79,23374 claims
PfizerEliquis$19$58,23051 claims
MerckJanuvia, Dulera$13$41,54535 claims
Johnson & JohnsonXarelto$58$19,04414 claims
AstraZenecaFarxiga, Symbicort$25$15,43628 claims
AbbVieSynthroid$32$2,08938 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Wheeling

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →